{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:06:08Z","timestamp":1761401168530},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.1038\/sj.gt.3302266","type":"journal-article","created":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T09:25:30Z","timestamp":1080811530000},"page":"1087-1098","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide"],"prefix":"10.1038","volume":"11","author":[{"given":"Rafaela","family":"Argnani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Boccafogli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy C","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Manservigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,4,1]]},"reference":[{"key":"BF3302266_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/83324","volume":"7","author":"MA Kay","year":"2001","unstructured":"Kay MA, Glorioso JC, Naldini L . Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33\u201340.","journal-title":"Nat Med"},{"key":"BF3302266_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev.pharmtox.43.100901.140257","volume":"43","author":"NA Kootstra","year":"2003","unstructured":"Kootstra NA, Verma IM . Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 2003; 43: 413\u2013439.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF3302266_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0167-7799(02)00042-2","volume":"21","author":"K Lundstrom","year":"2003","unstructured":"Lundstrom K . Latest development in viral vectors for gene therapy. Trends Biotechnol 2003; 21: 117\u2013122.","journal-title":"Trends Biotechnol"},{"key":"BF3302266_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2165\/00003088-200241120-00001","volume":"41","author":"C Mah","year":"2002","unstructured":"Mah C, Byrne BJ, Flotte TR . Virus-based gene delivery systems. Clin Pharmacokinet 2002; 41: 901\u2013911.","journal-title":"Clin Pharmacokinet"},{"key":"BF3302266_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0167-7799(97)01137-2","volume":"16","author":"PD Robbins","year":"1998","unstructured":"Robbins PD, Tahara H, Ghivizzani SC . Viral vectors for gene therapy. Trends Biotechnol 1998; 16: 35\u201340.","journal-title":"Trends Biotechnol"},{"key":"BF3302266_CR6","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1046\/j.1469-0691.2002.00432.x","volume":"8","author":"SJ Advani","year":"2002","unstructured":"Advani SJ, Weichselbaum RR, Whitley RJ, Roizman B . Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications. Clin Microbiol Infect 2002; 8: 551\u2013563.","journal-title":"Clin Microbiol Infect"},{"key":"BF3302266_CR7","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1128\/JVI.74.5.2481-2487.2000","volume":"74","author":"DB Anderson","year":"2000","unstructured":"Anderson DB et al. Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J Virol 2000; 74: 2481\u20132487.","journal-title":"J Virol"},{"key":"BF3302266_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0169-409X(01)00226-5","volume":"53","author":"EA Burton","year":"2001","unstructured":"Burton EA, Bai Q, Goins WF, Glorioso JC . Targeting gene expression using HSV vectors. Adv Drug Deliv Rev 2001; 53: 155\u2013170.","journal-title":"Adv Drug Deliv Rev"},{"key":"BF3302266_CR9","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/nbt1196-1574","volume":"14","author":"JT Douglas","year":"1996","unstructured":"Douglas JT . Targeted gene delivery by tropism-modified adenoviral vectors. Nat Biotechnol 1996; 14: 1574\u20131578.","journal-title":"Nat Biotechnol"},{"key":"BF3302266_CR10","doi-asserted-by":"publisher","first-page":"9747","DOI":"10.1073\/pnas.92.21.9747","volume":"92","author":"X Han","year":"1995","unstructured":"Han X, Kasahara N, Kan YW . Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 1995; 92: 9747\u20139751.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302266_CR11","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1128\/JVI.72.12.9683-9697.1998","volume":"72","author":"S Laquerre","year":"1998","unstructured":"Laquerre S, Anderson DB, Stolz DB, Glorioso JC . Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. J Virol 1998; 72: 9683\u20139697.","journal-title":"J Virol"},{"key":"BF3302266_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1566523023347797","volume":"2","author":"SA Nicklin","year":"2002","unstructured":"Nicklin SA, Baker AH . Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy. Curr Gene Ther 2002; 2: 273\u2013293.","journal-title":"Curr Gene Ther"},{"key":"BF3302266_CR13","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/jvi.68.7.4609-4619.1994","volume":"68","author":"S Valsesia-Wittmann","year":"1994","unstructured":"Valsesia-Wittmann S et al. Modification in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol 1994; 68: 4609\u20134619.","journal-title":"J Virol"},{"key":"BF3302266_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/BF02723784","volume":"69","author":"MM Aw","year":"2002","unstructured":"Aw MM, Dhawan A . Acute liver failure. Indian J Pediatr 2002; 69: 87\u201391.","journal-title":"Indian J Pediatr"},{"key":"BF3302266_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1053\/siny.2001.0086","volume":"7","author":"PT Clayton","year":"2002","unstructured":"Clayton PT . Inborn errors presenting with liver dysfunction. Semin Neonatol 2002; 7: 49\u201363.","journal-title":"Semin Neonatol"},{"key":"BF3302266_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.gt.3301947","volume":"10","author":"AA Stecenko","year":"2003","unstructured":"Stecenko AA, Brigham KL . Gene therapy progress and prospects: alpha-1 antitrypsin. Gene Therapy 2003; 10: 95\u201399.","journal-title":"Gene Therapy"},{"key":"BF3302266_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/jgm.329","volume":"5","author":"S Kobayashi","year":"2003","unstructured":"Kobayashi S et al. Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation. J Gene Med 2003; 5: 201\u2013208.","journal-title":"J Gene Med"},{"key":"BF3302266_CR18","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1440-1746.2002.02784.x","volume":"17","author":"ST Cheung","year":"2002","unstructured":"Cheung ST et al. Liver as an ideal target for gene therapy: expression of CTLA4Ig by retroviral gene transfer. J Gastroenterol Hepatol 2002; 17: 1008\u20131014.","journal-title":"J Gastroenterol Hepatol"},{"key":"BF3302266_CR19","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1089\/hum.1998.9.14-1975","volume":"9","author":"N Ferry","year":"1998","unstructured":"Ferry N, Heard JM . Liver-directed gene transfer vectors. Hum Gene Ther 1998; 9: 1975\u20131981.","journal-title":"Hum Gene Ther"},{"key":"BF3302266_CR20","first-page":"723","volume":"22","author":"Y Fong","year":"1995","unstructured":"Fong Y et al. Rapid and efficient gene transfer in human hepatocytes by herpes viral vectors. Hepatology 1995; 22: 723\u2013729.","journal-title":"Hepatology"},{"key":"BF3302266_CR21","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/sj.gt.3300613","volume":"5","author":"SJ Forbes","year":"1998","unstructured":"Forbes SJ et al. Retroviral gene transfer to the liver in vivo during tri-iodothyronine inducing hyperplasia. Gene Therapy 1998; 5: 552\u2013555.","journal-title":"Gene Therapy"},{"key":"BF3302266_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/BF03401718","volume":"3","author":"C Fraefel","year":"1997","unstructured":"Fraefel C et al. Gene transfer into hepatocytes mediated by helper virus-free HSV\/AAV hybrid vectors. Mol Med 1997; 3: 813\u2013825.","journal-title":"Mol Med"},{"key":"BF3302266_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s005340170050","volume":"8","author":"C Guha","year":"2001","unstructured":"Guha C, Roy-Chowdhury N, Jauregui H, Roy-Chowdhury J . Hepatocyte-based gene therapy. J Hepatobiliary Pancreat Surg 2001; 8: 51\u201357.","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"BF3302266_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/(SICI)1521-2254(199911\/12)1:6<386::AID-JGM73>3.0.CO;2-Z","volume":"1","author":"S Gupta","year":"1999","unstructured":"Gupta S, Malhi H, Gagandeep S, Novikoff P . Liver repopulation with hepatocyte transplantation: new avenues for gene and cell therapy. J Gene Med 1999; 1: 386\u2013392.","journal-title":"J Gene Med"},{"key":"BF3302266_CR25","first-page":"3016","volume":"61","author":"A Ido","year":"2001","unstructured":"Ido A et al. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by o hypoxia-inducible enhancer linked to a human \u00e1-fetoprotein promoter. Cancer Res 2001; 61: 3016\u20133021.","journal-title":"Cancer Res"},{"key":"BF3302266_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/sj.cgt.7700558","volume":"10","author":"WR Jarnagin","year":"2003","unstructured":"Jarnagin WR et al. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection. Cancer Gene Ther 2003; 10: 215\u2013223.","journal-title":"Cancer Gene Ther"},{"key":"BF3302266_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1089\/hum.1998.9.9-1293","volume":"9","author":"KI Kosai","year":"1998","unstructured":"Kosai KI et al. Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy. Hum Gene Ther 1998; 9: 1293\u20131301.","journal-title":"Hum Gene Ther"},{"key":"BF3302266_CR28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1053\/jlts.2002.36844","volume":"8","author":"BT Kren","year":"2002","unstructured":"Kren BT, Chowdhury NR, Chowdhury JR, Steer CJ . Gene therapy as an alternative to liver transplantation. Liver Transplant 2002; 8: 1098\u20131108.","journal-title":"Liver Transplant"},{"key":"BF3302266_CR29","first-page":"752","volume":"21","author":"B Lu","year":"1995","unstructured":"Lu B, Gupta S, Federoff H . Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vector. Hepatology 1995; 21: 752\u2013759.","journal-title":"Hepatology"},{"key":"BF3302266_CR30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1006\/bbrc.2001.5495","volume":"286","author":"V Pichard","year":"2001","unstructured":"Pichard V, Aubert D, Ferry N . Efficient retroviral gene transfer to the liver in vivo using nonpolypeptidic mitogens. Biochem Biophys Res Commun 2001; 286: 929\u2013935.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF3302266_CR31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0065-3527(00)55011-8","volume":"55","author":"C Fraefel","year":"2000","unstructured":"Fraefel C, Jacoby DR, Breakefield XO . Herpes simplex virus type 1-based amplicon vector systems. Adv Virus Res 2000; 55: 425\u2013451.","journal-title":"Adv Virus Res"},{"key":"BF3302266_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S1054-3589(08)60139-8","volume":"40","author":"JC Glorioso","year":"1997","unstructured":"Glorioso JC et al. Engineering herpes simplex virus vectors for human gene therapy. Adv Pharmacol 1997; 40: 103\u2013136.","journal-title":"Adv Pharmacol"},{"key":"BF3302266_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(01)00322-5","volume":"264","author":"DS Latchman","year":"2001","unstructured":"Latchman DS . Gene delivery and gene therapy with herpes simplex virus-based vectors. Gene 2001; 264: 1\u20139.","journal-title":"Gene"},{"key":"BF3302266_CR34","first-page":"61","volume":"76","author":"CJ Link","year":"2003","unstructured":"Link CJ, Vahanian NN, Wang S . Herpes simplex amplicon vectors. Methods Mol Med 2003; 76: 61\u201387.","journal-title":"Methods Mol Med"},{"key":"BF3302266_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0958-1669(02)00359-2","volume":"13","author":"EA Burton","year":"2002","unstructured":"Burton EA, Bai Q, Goins WF, Glorioso JC . Replication-defective genomic herpes simplex vectors: design and production. Curr Opin Biotechnol 2002; 13: 424\u2013428.","journal-title":"Curr Opin Biotechnol"},{"key":"BF3302266_CR36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/sj.gt.3300755","volume":"5","author":"DM Krisky","year":"1998","unstructured":"Krisky DM et al. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Therapy 1998; 5: 1517\u20131530.","journal-title":"Gene Therapy"},{"key":"BF3302266_CR37","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/sj.gt.3300766","volume":"5","author":"DM Krisky","year":"1998","unstructured":"Krisky DM et al. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Therapy 1998; 5: 1593\u20131603.","journal-title":"Gene Therapy"},{"key":"BF3302266_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.gt.3301620","volume":"9","author":"SM Chung","year":"2002","unstructured":"Chung SM et al. The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma. Gene Therapy 2002; 9: 75\u201380.","journal-title":"Gene Therapy"},{"key":"BF3302266_CR39","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0065-3527(00)55010-6","volume":"55","author":"NS Markovitz","year":"2000","unstructured":"Markovitz NS, Roizman B . Replication-competent herpes simplex viral vectors for cancer therapy. Adv Virus Res 2000; 55: 409\u2013424.","journal-title":"Adv Virus Res"},{"key":"BF3302266_CR40","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/cncr.10776","volume":"95","author":"TM Pawlik","year":"2002","unstructured":"Pawlik TM et al. Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene. Cancer 2002; 95: 1171\u20131181.","journal-title":"Cancer"},{"key":"BF3302266_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1517\/13543784.9.8.1841","volume":"9","author":"ER Smith","year":"2000","unstructured":"Smith ER, Chiocca EA . Oncolytic viruses as novel anticancer agents: turning one scourge against another. Expert Opin Invest Drugs 2000; 9: 311\u2013327.","journal-title":"Expert Opin Invest Drugs"},{"key":"BF3302266_CR42","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/JVI.72.7.6119-6130.1998","volume":"72","author":"S Laquerre","year":"1998","unstructured":"Laquerre S et al. Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contribution to virus attachment, penetration, and cell-to-cell spread. J Virol 1998; 72: 6119\u20136130.","journal-title":"J Virol"},{"key":"BF3302266_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0092-8674(00)80058-6","volume":"99","author":"D Shukla","year":"1999","unstructured":"Shukla D et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999; 99: 13\u201322.","journal-title":"Cell"},{"key":"BF3302266_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0092-8674(00)81363-X","volume":"87","author":"RI Montgomery","year":"1996","unstructured":"Montgomery RI, Warner MS, Brian JL, Spear PG . Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF\/NGF receptor family. Cell 1996; 87: 427\u2013436.","journal-title":"Cell"},{"key":"BF3302266_CR45","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1128\/JVI.73.10.8127-8137.1999","volume":"73","author":"C Krummenacher","year":"1999","unstructured":"Krummenacher C et al. The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol 1999; 73: 8127\u20138137.","journal-title":"J Virol"},{"key":"BF3302266_CR46","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/jvi.62.8.2596-2604.1988","volume":"62","author":"W Cai","year":"1988","unstructured":"Cai W, Gu B, Person S . Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol 1988; 62: 2596\u20132604.","journal-title":"J Virol"},{"key":"BF3302266_CR47","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1099\/0022-1317-69-6-1147","volume":"69","author":"P Desai","year":"1988","unstructured":"Desai P, Homa FL, Person S, Glorioso JC . Excretion of non-infectious virus particles lacking glycoprotein H by a temperature-sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J Virol 1988; 69: 1147\u20131156.","journal-title":"J Virol"},{"key":"BF3302266_CR48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/jvi.68.2.834-845.1994","volume":"68","author":"KS Dingwell","year":"1994","unstructured":"Dingwell KS et al. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junction of cultured cells. J Virol 1994; 68: 834\u2013845.","journal-title":"J Virol"},{"key":"BF3302266_CR49","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1128\/jvi.62.5.1486-1494.1988","volume":"62","author":"MW Ligas","year":"1988","unstructured":"Ligas MW, Johnson DC . A herpes simplex virus mutant in which glycoprotein D sequences are replaced by \u03b2-galactosidase sequences binds to but is unable to penetrate into cells. J Virol 1988; 62: 1486\u20131494.","journal-title":"J Virol"},{"key":"BF3302266_CR50","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1128\/jvi.67.4.2285-2297.1993","volume":"67","author":"C Roop","year":"1993","unstructured":"Roop C, Hutchinson L, Johnson DC . A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol 1993; 67: 2285\u20132297.","journal-title":"J Virol"},{"key":"BF3302266_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0092-8674(86)90663-X","volume":"46","author":"AR Neurath","year":"1986","unstructured":"Neurath AR, Kent SB, Strick N, Parker K . Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986; 46: 429\u2013436.","journal-title":"Cell"},{"key":"BF3302266_CR52","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/viro.1994.1558","volume":"204","author":"AR Neurath","year":"1994","unstructured":"Neurath AR, Strick N . The putative cell receptor for hepatitis B virus (HBV), annexin V, and apolipoprotein H, bind to lipid components of HBV. Virology 1994; 204: 475\u2013477.","journal-title":"Virology"},{"key":"BF3302266_CR53","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0042-6822(91)90062-G","volume":"180","author":"MA Petit","year":"1991","unstructured":"Petit MA et al. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1 (21-47). Virology 1991; 180: 483\u2013491.","journal-title":"Virology"},{"key":"BF3302266_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0042-6822(92)90309-D","volume":"187","author":"MA Petit","year":"1992","unstructured":"Petit MA, Capel F, Dubanchet S, Mabit H . PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 1992; 187: 211\u2013222.","journal-title":"Virology"},{"key":"BF3302266_CR55","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/jvi.45.2.634-647.1983","volume":"45","author":"RJ Fink","year":"1983","unstructured":"Fink RJ, Eisenberg RJ, Cohen GH, Wagner EK . Detailed analysis of the portion of the herpes simplex virus type 1 genome encoding glycoprotein C. J Virol 1983; 45: 634\u2013647.","journal-title":"J Virol"},{"key":"BF3302266_CR56","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1099\/0022-1317-82-8-1941","volume":"82","author":"K Mardberg","year":"2001","unstructured":"Mardberg K, Trybala E, Glorioso JC, Bergstrom T . Mutational analysis of heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. J Gen Virol 2001; 82: 1941\u20131950.","journal-title":"J Gen Virol"},{"key":"BF3302266_CR57","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1128\/jvi.67.1.189-195.1993","volume":"67","author":"KE Dolter","year":"1993","unstructured":"Dolter KE, King SR, Holland TC . Incorporation of CD4 into virions by recombinant herpes simplex virus. J Virol 1993; 67: 189\u2013195.","journal-title":"J Virol"},{"key":"BF3302266_CR58","doi-asserted-by":"publisher","first-page":"15124","DOI":"10.1073\/pnas.232588699","volume":"99","author":"G Zhou","year":"2002","unstructured":"Zhou G, Ye GJ, Debinski W, Roizman B . Engineered herpes simplex virus 1 is dependent on IL13R\u03b12 receptor for cell entry and independent of glycoprotein D receptor interactions. Proc Natl Acad Sci USA 2002; 99: 15124\u201315129.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302266_CR59","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1128\/JVI.72.10.7745-7753.1998","volume":"72","author":"RE Dutch","year":"1988","unstructured":"Dutch RE, Bagai Joshi S, Lamb RA . Membrane fusion promoted by increasing surface densities of the paramyxovirus F and HN proteins: comparison of fusion reactions mediated by simian virus 5 F, human parainfluenza virus type 3 F, and influenza virus HA. J Virol 1988; 72: 7745\u20137753.","journal-title":"J Virol"},{"key":"BF3302266_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0022-1759(86)90313-3","volume":"95","author":"E Takai","year":"1986","unstructured":"Takai E et al. A solid-phase enzyme immunoassay for the determination of IgM and IgG antibodies against translation products of pre-S1 and pre-S2 regions of hepatitis B virus. J Immunol Methods 1986; 95: 23\u201330.","journal-title":"J Immunol Methods"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302266","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302266.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:21:10Z","timestamp":1648614070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":60,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2004,7,1]]}},"alternative-id":["BF3302266"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302266","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,1]]},"assertion":[{"value":"1 August 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}